ID

32916

Descrizione

A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED); ODM derived from: https://clinicaltrials.gov/show/NCT00902161

collegamento

https://clinicaltrials.gov/show/NCT00902161

Keywords

versioni (1)
  1. 20/11/18 20/11/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

20 novembre 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Type 2 Diabetes Mellitus NCT00902161

Inglese

Eligibility Type 2 Diabetes Mellitus NCT00902161

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
participant has type 2 diabetes (t2dm)
Descrizione

Diabetes Mellitus, Non-Insulin-Dependent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011860
participant is either: not on an oral antihyperglycemic medication for at least 6 weeks; on a single oral antihyperglycemic medication that is not a peroxisome proliferator-activated gamma (ppar-gamma) agonist (e.g. avandia); or on a combination of no more than two antihyperglycemic medications that are not ppar-gamma) agonists
Descrizione

Oral hypoglycemic Absent | Oral hypoglycemic Single | Exception PPAR-gamma Agonist | Exception Avandia | Combination Hypoglycemic Agents Quantity | Exception PPAR-gamma Agonist

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0359086
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0359086
UMLS CUI [2,2]
C0205171
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C2917405
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0875967
UMLS CUI [5,1]
C0205195
UMLS CUI [5,2]
C0020616
UMLS CUI [5,3]
C1265611
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C2917405
participant has not received insulin for at least 6 months
Descrizione

Insulin Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0332197
participant has not been treated with a ppar-gamma agonist for at least 12 weeks
Descrizione

PPAR gamma Agonists Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2916798
UMLS CUI [1,2]
C0332197
participant has been a nonsmoker for at least 6 months
Descrizione

Non-smoker Duration

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0337672
UMLS CUI [1,2]
C0449238
female participants who are non-pregnant and highly unlikely to conceive due to surgical sterilization, post-menopausal status, not heterosexually active, or willing to use 2 birth control methods
Descrizione

Gender | Pregnancy Absent | Pregnancy Unlikely | Female Sterilization | Postmenopausal state | Heterosexual activity Absent | Contraceptive methods Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0032961
UMLS CUI [3,2]
C0750558
UMLS CUI [4]
C0015787
UMLS CUI [5]
C0232970
UMLS CUI [6,1]
C4272228
UMLS CUI [6,2]
C0332197
UMLS CUI [7,1]
C0700589
UMLS CUI [7,2]
C1265611
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
participant has a history of stroke, seizures, or neurological disorders
Descrizione

Cerebrovascular accident | Seizures | Nervous system disorder

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0036572
UMLS CUI [3]
C0027765
participant cannot tolerate insulin or propranolol
Descrizione

Intolerance to Insulin | Intolerance to Propranolol

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0021641
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0033497
participant has a history of asthma, emphysema or chronic bronchitis
Descrizione

Asthma | Emphysema | Bronchitis, Chronic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2]
C0034067
UMLS CUI [3]
C0008677
participant is on a weight loss program that is not in the maintenance phase or has been treated with a weight loss medication within 8 weeks of screening
Descrizione

Weight Reduction Program | Maintenance Phase Absent | Weight-Loss Agents

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3179079
UMLS CUI [2,1]
C0024501
UMLS CUI [2,2]
C0205390
UMLS CUI [2,3]
C0332197
UMLS CUI [3]
C0376606
participant is on or may require treatment with drugs that affect the immune system or with corticosteroids
Descrizione

Pharmaceutical Preparations Affecting Immune system | Adrenal Cortex Hormones

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0020962
UMLS CUI [2]
C0001617
participant has a history of heart failure or coronary artery disease
Descrizione

Heart failure | Coronary Artery Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0018801
UMLS CUI [2]
C1956346
participant has a history of uncontrolled high blood pressure
Descrizione

Uncontrolled hypertension

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1868885
participant is human immunodeficiency (hiv), hepatitis b or hepatitis c positive
Descrizione

HIV Seropositivity | Hepatitis B positive | Hepatitis C positive

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0856706
UMLS CUI [3]
C1112419
participant has a history of type 1 diabetes
Descrizione

Diabetes Mellitus, Insulin-Dependent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011854
participant has a history of hypoglycemia unawareness documented by a blood glucose concentration < 55 mg/dl (3.1 mol/l) without symptoms of hypoglycemia.
Descrizione

Loss of hypoglycemic warning | Blood glucose concentration | Symptoms Absent Hypoglycemia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0342317
UMLS CUI [2]
C2585282
UMLS CUI [3,1]
C1457887
UMLS CUI [3,2]
C0332197
UMLS CUI [3,3]
C0020615
Ritorna all'inizio della pagina

Similar models

Eligibility Type 2 Diabetes Mellitus NCT00902161

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
participant has type 2 diabetes (t2dm)
boolean
C0011860 (UMLS CUI [1])
Oral hypoglycemic Absent | Oral hypoglycemic Single | Exception PPAR-gamma Agonist | Exception Avandia | Combination Hypoglycemic Agents Quantity | Exception PPAR-gamma Agonist
Item
participant is either: not on an oral antihyperglycemic medication for at least 6 weeks; on a single oral antihyperglycemic medication that is not a peroxisome proliferator-activated gamma (ppar-gamma) agonist (e.g. avandia); or on a combination of no more than two antihyperglycemic medications that are not ppar-gamma) agonists
boolean
C0359086 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0359086 (UMLS CUI [2,1])
C0205171 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C2917405 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0875967 (UMLS CUI [4,2])
C0205195 (UMLS CUI [5,1])
C0020616 (UMLS CUI [5,2])
C1265611 (UMLS CUI [5,3])
C1705847 (UMLS CUI [6,1])
C2917405 (UMLS CUI [6,2])
Insulin Absent
Item
participant has not received insulin for at least 6 months
boolean
C0021641 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
PPAR gamma Agonists Absent
Item
participant has not been treated with a ppar-gamma agonist for at least 12 weeks
boolean
C2916798 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Non-smoker Duration
Item
participant has been a nonsmoker for at least 6 months
boolean
C0337672 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Gender | Pregnancy Absent | Pregnancy Unlikely | Female Sterilization | Postmenopausal state | Heterosexual activity Absent | Contraceptive methods Quantity
Item
female participants who are non-pregnant and highly unlikely to conceive due to surgical sterilization, post-menopausal status, not heterosexually active, or willing to use 2 birth control methods
boolean
C0079399 (UMLS CUI [1])
C0032961 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0032961 (UMLS CUI [3,1])
C0750558 (UMLS CUI [3,2])
C0015787 (UMLS CUI [4])
C0232970 (UMLS CUI [5])
C4272228 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
C0700589 (UMLS CUI [7,1])
C1265611 (UMLS CUI [7,2])
Item Group
C0680251 (UMLS CUI)
Cerebrovascular accident | Seizures | Nervous system disorder
Item
participant has a history of stroke, seizures, or neurological disorders
boolean
C0038454 (UMLS CUI [1])
C0036572 (UMLS CUI [2])
C0027765 (UMLS CUI [3])
Intolerance to Insulin | Intolerance to Propranolol
Item
participant cannot tolerate insulin or propranolol
boolean
C1744706 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0033497 (UMLS CUI [2,2])
Asthma | Emphysema | Bronchitis, Chronic
Item
participant has a history of asthma, emphysema or chronic bronchitis
boolean
C0004096 (UMLS CUI [1])
C0034067 (UMLS CUI [2])
C0008677 (UMLS CUI [3])
Weight Reduction Program | Maintenance Phase Absent | Weight-Loss Agents
Item
participant is on a weight loss program that is not in the maintenance phase or has been treated with a weight loss medication within 8 weeks of screening
boolean
C3179079 (UMLS CUI [1])
C0024501 (UMLS CUI [2,1])
C0205390 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0376606 (UMLS CUI [3])
Pharmaceutical Preparations Affecting Immune system | Adrenal Cortex Hormones
Item
participant is on or may require treatment with drugs that affect the immune system or with corticosteroids
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0020962 (UMLS CUI [1,3])
C0001617 (UMLS CUI [2])
Heart failure | Coronary Artery Disease
Item
participant has a history of heart failure or coronary artery disease
boolean
C0018801 (UMLS CUI [1])
C1956346 (UMLS CUI [2])
Uncontrolled hypertension
Item
participant has a history of uncontrolled high blood pressure
boolean
C1868885 (UMLS CUI [1])
HIV Seropositivity | Hepatitis B positive | Hepatitis C positive
Item
participant is human immunodeficiency (hiv), hepatitis b or hepatitis c positive
boolean
C0019699 (UMLS CUI [1])
C0856706 (UMLS CUI [2])
C1112419 (UMLS CUI [3])
Diabetes Mellitus, Insulin-Dependent
Item
participant has a history of type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Loss of hypoglycemic warning | Blood glucose concentration | Symptoms Absent Hypoglycemia
Item
participant has a history of hypoglycemia unawareness documented by a blood glucose concentration < 55 mg/dl (3.1 mol/l) without symptoms of hypoglycemia.
boolean
C0342317 (UMLS CUI [1])
C2585282 (UMLS CUI [2])
C1457887 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0020615 (UMLS CUI [3,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial